← Insider buys
RVNC

Revance Therapeutics, Inc.

CFO, CBO, Secretary Lauren P Silvernail sold $106K of Revance Therapeutics, Inc.

Sold$105,839
$30.85Price
3,431Shares
−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 22. Filed Fri, Mar 23, 5:12 PM ET, after the close. Not investment advice.